Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 380 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 380 · Balance 380 F1: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2: Annual non-employee director award. F3: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. F4: Not applicable as restricted stock units do not have an expiration date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $527.07 · Expires 2033-07-22 | Direct | 3,570 |
Reported balance
After 2026-07-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-22 · Grant · Acquired 1,190 · Balance 3,570 F2: Annual non-employee director award. F3: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. |
| Common StockSEC Table I · non-derivative | Direct | 450 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 450 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F2: Annual non-employee director award.
F3: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
F4: Not applicable as restricted stock units do not have an expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2026 Filed Jul 23, 2026 20:43 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Option · Derivative | 1,190 | $0.00 Strike: $527.07 | $0.00 |
DisclosureSEC source: 0002028640-26-000008 · primarydocument.xml · derivative · entry 3 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,570 Underlying: Common Stock · 1,190 shares Expires 2033-07-22 F2 · shares: Annual non-employee director award. F3 · derivative.exercise_date: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. Read SEC document |
| July 22, 2026 Filed Jul 23, 2026 20:43 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 380 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002028640-26-000008 · primarydocument.xml · derivative · entry 2 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 380 Underlying: Common Stock · 380 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director award. F3 · derivative.exercise_date: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 10, 2026 Filed Jul 10, 2026 20:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 325 | $550.59 | $178,941.75 |
DisclosureSEC source: 0002028640-26-000007 · primarydocument.xml · nonDerivative · entry 2 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 450 F2 · kind: This is a sale of common stock pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on September 11, 2025. Read SEC document |
| July 09, 2026 Filed Jul 10, 2026 20:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002028640-26-000007 · primarydocument.xml · derivative · entry 3 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 09, 2026 Filed Jul 10, 2026 20:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0002028640-26-000007 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| March 17, 2026 Filed Mar 17, 2026 20:56 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 45 | $533.51 | $24,007.95 |
DisclosureSEC source: 0002028640-26-000006 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125 F1 · kind: This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 11, 2025. Read SEC document |
| March 03, 2026 Filed Mar 3, 2026 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 50 | $509.20 | $25,460.00 |
DisclosureSEC source: 0002028640-26-000005 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 170 F1 · kind: This is a sale of common stock pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on September 11, 2025. Read SEC document |
| February 17, 2026 Filed Feb 17, 2026 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 50 | $474.68 | $23,734.00 |
DisclosureSEC source: 0002028640-26-000004 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220 F1 · kind: This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 11, 2025. Read SEC document |
| February 03, 2026 Filed Feb 3, 2026 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 50 | $474.23 | $23,711.50 |
DisclosureSEC source: 0002028640-26-000003 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270 F1 · kind: This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 11, 2025. Read SEC document |
| January 16, 2026 Filed Jan 20, 2026 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 50 | $460.98 | $23,049.00 |
DisclosureSEC source: 0002028640-26-000002 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 320 F1 · kind: This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 11, 2025. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 50 | $495.01 | $24,750.50 |
DisclosureSEC source: 0002028640-26-000001 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 370 F1 · kind: This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 11, 2025. Read SEC document |
| December 23, 2025 Filed Dec 23, 2025 21:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 50 | $512.12 | $25,606.00 |
DisclosureSEC source: 0002028640-25-000006 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 420 F1 · kind: This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 11, 2025. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 50 | $482.98 | $24,149.00 |
DisclosureSEC source: 0002028640-25-000005 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 470 F1 · kind: This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 11, 2025. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 700 | $400.29 | $280,203.00 |
DisclosureSEC source: 0002028640-25-000004 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520 Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · derivative · entry 4 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 590 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · nonDerivative · entry 2 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 1,830 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · derivative · entry 6 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 1,830 shares Expires 2035-07-24 F5 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · derivative · entry 5 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock · 650 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F5 · shares: Annual non-employee director award. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| June 26, 2025 Filed Jul 28, 2025 10:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 630 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · derivative · entry 3 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on June 26, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| June 26, 2025 Filed Jul 28, 2025 10:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · nonDerivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on June 26, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on June 26, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-020165 · form4-07262024_040709.xml · derivative · entry 2 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 590 Underlying: Common Stock · 590 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F1 · shares: Annual non-employee director award. F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 1,440 | $0.00 Strike: $336.37 | $0.00 |
DisclosureSEC source: 0001415889-24-020165 · form4-07262024_040709.xml · derivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,440 Underlying: Common Stock · 1,440 shares Expires 2034-07-25 F1 · shares: Annual non-employee director award. F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date. Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 630 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-018444 · form4-06282024_080603.xml · derivative · entry 2 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630 Underlying: Common Stock · 630 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F1 · derivative.exercise_date: In connection with Jan Malcolm's election to the Board of Directors on June 26, 2024, she was awarded a combination of Restricted Stock Units and Stock Options in accordance with the Non-Employee Director Compensation Program. Each award becomes fully vested on the one-year anniversary of the grant date. F1 · derivative.expiration_date: In connection with Jan Malcolm's election to the Board of Directors on June 26, 2024, she was awarded a combination of Restricted Stock Units and Stock Options in accordance with the Non-Employee Director Compensation Program. Each award becomes fully vested on the one-year anniversary of the grant date. Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 1,520 | $0.00 Strike: $318.95 | $0.00 |
DisclosureSEC source: 0001415889-24-018444 · form4-06282024_080603.xml · derivative · entry 1 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,520 Underlying: Common Stock · 1,520 shares Expires 2034-06-26 F1 · derivative.exercise_date: In connection with Jan Malcolm's election to the Board of Directors on June 26, 2024, she was awarded a combination of Restricted Stock Units and Stock Options in accordance with the Non-Employee Director Compensation Program. Each award becomes fully vested on the one-year anniversary of the grant date. F1 · derivative.expiration_date: In connection with Jan Malcolm's election to the Board of Directors on June 26, 2024, she was awarded a combination of Restricted Stock Units and Stock Options in accordance with the Non-Employee Director Compensation Program. Each award becomes fully vested on the one-year anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.